These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 27594594)

  • 21. Hijacking microglial glutathione by inorganic arsenic impels bystander death of immature neurons through extracellular cystine/glutamate imbalance.
    Singh V; Gera R; Kushwaha R; Sharma AK; Patnaik S; Ghosh D
    Sci Rep; 2016 Aug; 6():30601. PubMed ID: 27477106
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Iron regulates L-cystine uptake and glutathione levels in lens epithelial and retinal pigment epithelial cells by its effect on cytosolic aconitase.
    Lall MM; Ferrell J; Nagar S; Fleisher LN; McGahan MC
    Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):310-9. PubMed ID: 18172108
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy.
    Koppula P; Zhuang L; Gan B
    Protein Cell; 2021 Aug; 12(8):599-620. PubMed ID: 33000412
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of the effects of polyunsaturated fatty acids on transporter expressions using a PCR array: Induction of xCT/SLC7A11 in human placental BeWo cells.
    Ono K; Furugen A; Kurosawa Y; Jinno N; Narumi K; Kobayashi M; Iseki K
    Placenta; 2019 Jan; 75():34-41. PubMed ID: 30712664
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Negative regulation of osteoblastogenesis through downregulation of runt-related transcription factor-2 in osteoblastic MC3T3-E1 cells with stable overexpression of the cystine/glutamate antiporter xCT subunit.
    Uno K; Takarada T; Takarada-Iemata M; Nakamura Y; Fujita H; Hinoi E; Yoneda Y
    J Cell Physiol; 2011 Nov; 226(11):2953-64. PubMed ID: 21302293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cystine-glutamate antiporter xCT deficiency suppresses tumor growth while preserving antitumor immunity.
    Arensman MD; Yang XS; Leahy DM; Toral-Barza L; Mileski M; Rosfjord EC; Wang F; Deng S; Myers JS; Abraham RT; Eng CH
    Proc Natl Acad Sci U S A; 2019 May; 116(19):9533-9542. PubMed ID: 31019077
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A cystine-cysteine shuttle mediated by xCT facilitates cellular responses to S-nitrosoalbumin.
    Zhu J; Li S; Marshall ZM; Whorton AR
    Am J Physiol Cell Physiol; 2008 Apr; 294(4):C1012-20. PubMed ID: 18287333
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myeloid-derived suppressor cells inhibit T-cell activation by depleting cystine and cysteine.
    Srivastava MK; Sinha P; Clements VK; Rodriguez P; Ostrand-Rosenberg S
    Cancer Res; 2010 Jan; 70(1):68-77. PubMed ID: 20028852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vasodilator oxyfedrine inhibits aldehyde metabolism and thereby sensitizes cancer cells to xCT-targeted therapy.
    Otsuki Y; Yamasaki J; Suina K; Okazaki S; Koike N; Saya H; Nagano O
    Cancer Sci; 2020 Jan; 111(1):127-136. PubMed ID: 31692172
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A prominent role for mucosal cystine/cysteine metabolism in intestinal immunoregulation.
    Sido B; Lasitschka F; Giese T; Gassler N; Funke B; Schröder-Braunstein J; Brunnemer U; Meuer SC; Autschbach F
    Gastroenterology; 2008 Jan; 134(1):179-91. PubMed ID: 18061179
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure, function, and regulation of human cystine/glutamate transporter in retinal pigment epithelial cells.
    Bridges CC; Kekuda R; Wang H; Prasad PD; Mehta P; Huang W; Smith SB; Ganapathy V
    Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):47-54. PubMed ID: 11133847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional interactions of the cystine/glutamate antiporter, CD44v and MUC1-C oncoprotein in triple-negative breast cancer cells.
    Hasegawa M; Takahashi H; Rajabi H; Alam M; Suzuki Y; Yin L; Tagde A; Maeda T; Hiraki M; Sukhatme VP; Kufe D
    Oncotarget; 2016 Mar; 7(11):11756-69. PubMed ID: 26930718
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Erastin sensitizes glioblastoma cells to temozolomide by restraining xCT and cystathionine-γ-lyase function.
    Chen L; Li X; Liu L; Yu B; Xue Y; Liu Y
    Oncol Rep; 2015 Mar; 33(3):1465-74. PubMed ID: 25585997
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic Ablation of the Cystine Transporter xCT in PDAC Cells Inhibits mTORC1, Growth, Survival, and Tumor Formation via Nutrient and Oxidative Stresses.
    Daher B; Parks SK; Durivault J; Cormerais Y; Baidarjad H; Tambutte E; Pouysségur J; Vučetić M
    Cancer Res; 2019 Aug; 79(15):3877-3890. PubMed ID: 31175120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The glutamate/cystine antiporter SLC7A11/xCT enhances cancer cell dependency on glucose by exporting glutamate.
    Koppula P; Zhang Y; Shi J; Li W; Gan B
    J Biol Chem; 2017 Aug; 292(34):14240-14249. PubMed ID: 28630042
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disruption of xCT inhibits cancer cell metastasis via the caveolin-1/beta-catenin pathway.
    Chen RS; Song YM; Zhou ZY; Tong T; Li Y; Fu M; Guo XL; Dong LJ; He X; Qiao HX; Zhan QM; Li W
    Oncogene; 2009 Jan; 28(4):599-609. PubMed ID: 19015640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Redox-dependent AMPK inactivation disrupts metabolic adaptation to glucose starvation in xCT-overexpressing cancer cells.
    Lee Y; Itahana Y; Ong CC; Itahana K
    J Cell Sci; 2022 Aug; 135(15):. PubMed ID: 35775474
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cystine-glutamate transporter SLC7A11 in cancer chemosensitivity and chemoresistance.
    Huang Y; Dai Z; Barbacioru C; Sadée W
    Cancer Res; 2005 Aug; 65(16):7446-54. PubMed ID: 16103098
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kinetic analysis of cystine uptake and inhibition pattern of sulfasalazine in A549 cells.
    Okamoto K; Saito Y; Ueda H; Narumi K; Furugen A; Kobayashi M
    Biopharm Drug Dispos; 2021 Sep; 42(8):389-392. PubMed ID: 34287957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery of the Inhibitor Targeting the SLC7A11/xCT Axis through In Silico and In Vitro Experiments.
    Yue J; Yin Y; Feng X; Xu J; Li Y; Li T; Liang S; He X; Liu Z; Wang Y
    Int J Mol Sci; 2024 Jul; 25(15):. PubMed ID: 39125853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.